Researcher verification RetaNord sells research peptides for laboratory and in vitro research only.

Verified researcher · 21+ · Research use only

Free EU shipping over €200 · For research use only
⚡ Fast checkout · ships in 24–48h Pay Pay VISA
Retatrutide hub

Retatrutide (Reta) in Europe

Retatrutide, often called Reta, is Eli Lilly's investigational triple agonist of the GLP-1, GIP and glucagon receptors. Here you will find our guides, prices and delivery details. RetaNord supplies it for laboratory research use only.

Order Retatrutide

Retatrutide (Reta) 10 mg from €67.46 per vial. Each batch goes through 7 tests, the certificate comes in the box, and orders ship from EU stock.

Guides and comparisons

Explainer

What is retatrutide?

Retatrutide is an experimental once-weekly peptide from Eli Lilly (LY3437943) that activates three hormone receptors: GLP-1, GIP and glucagon. What it is, who…

Mechanism

How does retatrutide work?

Retatrutide is a once-weekly triple agonist that activates GLP-1, GIP and glucagon receptors. Here is how each receptor works, what the trials show, and its…

Comparison

Ozempic vs retatrutide (Reta): the differences

Ozempic (semaglutide) vs retatrutide: one receptor vs three, weight change in trials (14.9% vs 28.3%), side effects and approval. Is reta the same as Ozempic?

Comparison

Retatrutide vs tirzepatide

Retatrutide is a triple agonist (GLP-1, GIP, glucagon) still in trials; tirzepatide is an approved dual agonist (GLP-1, GIP). How they differ in mechanism…

Comparison

Foundayo vs Wegovy pill vs retatrutide (Reta)

Foundayo vs Wegovy pill vs retatrutide (Reta): two daily GLP-1 pills and a weekly triple-agonist injection in trials. Weight loss, side effects, EU status.

Use-case Guide

Retatrutide & GLP-1 Side Effects: What the Trials Report

Adverse events recorded in published GLP-1 and multi-receptor agonist trials, and what the peptides often named alongside this class are separately studied…

Regulatory status

Is retatrutide FDA approved?

No. As of August 2026 retatrutide is not approved by the FDA or EMA. It is in Phase 3 TRIUMPH trials, with an approval filing expected around early 2027. Full…

Safety

Is retatrutide safe?

Retatrutide is still in trials, so its long-term safety is not fully established. What the trial safety data shows, the most common side effects, and what…

Quick answer

Retatrutide and lean mass: what the trials report

What body-composition sub-analyses of incretin-class trials report about lean mass, and what the separate lean-mass literature examines. Reference only, not…

Prices

How much does Reta (retatrutide) cost in Europe?

How much Reta (retatrutide) costs in Europe: €89.95 for one 10 mg vial at RetaNord, €67.46 per vial in a 10-pack (€6.75 to €9.00 per mg). Kit vials go lower.

Delivery by country

The same price in all 27 EU countries, delivered in about 3–4 business days. Pick your country:

Austria · Belgium · Bulgaria · Croatia · Cyprus · Czechia · Denmark · Estonia · Finland · France · Germany · Greece · Hungary · Ireland · Italy · Latvia · Lithuania · Luxembourg · Malta · Netherlands · Poland · Portugal · Romania · Slovakia · Slovenia · Spain · Sweden

Support

Contact us any time

A person answers every message — the same day, seven days a week.

Order now